← Back
Data updated: Mar 10, 2026
VIVUS INC
MetabolicOncology
VIVUS INC is a biotechnology company focused on Metabolic, Oncology. Key products include QSYMIA.
2010
Since
3
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 80%
1 drugs Phase 1: 2
Oncology 20%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...